SCHEMBL9876904

SCHEMBL9876904

CCN(CC)CCNC(=O)COc1ccc(-c2nn(-c3ccccc3)c3ncccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP3A4 P08684 1/20 0.50
MAPT P10636 3/20 0.44
HTT P42858 1/20 0.44
CCR6 P51684 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
LMNA P02545 4/20 0.43
HPGD P15428 2/20 0.43
RXFP1 Q9HBX9 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPK1 P28482 1/20 0.42
TP53 P04637 1/20 0.40
GLA P06280 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9236150 0.96 CYP1A2 (0.47) CYP1A2CYP2D6CYP3A4MAPTHTT
Fumaric Acid SCHEMBL9236146 0.96 CYP1A2 (0.47) CYP1A2CYP2D6CYP3A4MAPTHTT
SCHEMBL9876805 0.91 LMNA (0.44) MAPTSMN1; SMN2LMNAHPGDRXFP1
SCHEMBL9237439 0.88 CYP1A2 (0.43) CYP1A2CYP2D6CYP3A4MAPTHTT
Fumaric Acid SCHEMBL9236944 0.87 LMNA (0.41) MAPTSMN1; SMN2LMNAHPGDRXFP1
Maleic Acid SCHEMBL9236940 0.87 LMNA (0.41) MAPTSMN1; SMN2LMNAHPGDRXFP1
SCHEMBL9236865 0.82 PTGER1 (0.49) HTTSMN1; SMN2LMNAHPGDMAPK1
SCHEMBL9235670 0.80 MAPT (0.50) MAPTSMN1; SMN2HPGDALDH1A1MAPK1
SCHEMBL10593084 0.79 TNK2 (0.46) CYP1A2CYP2D6MAPTHTTALDH1A1
Maleic Acid SCHEMBL9235189 0.79 BCHE (0.44) CYP1A2CYP2D6MAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5006520-A Antibiotics, antitumor agents, treatment of blood disorders YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1991-04-09 US disclosed